Jasmine Choi

3.1k total citations · 2 hit papers
19 papers, 2.3k citations indexed

About

Jasmine Choi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jasmine Choi has authored 19 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jasmine Choi's work include Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (4 papers) and Diabetes Management and Research (3 papers). Jasmine Choi is often cited by papers focused on Diabetes Treatment and Management (5 papers), Pancreatic function and diabetes (4 papers) and Diabetes Management and Research (3 papers). Jasmine Choi collaborates with scholars based in United States, Italy and United Kingdom. Jasmine Choi's co-authors include Nayyar Iqbal, Robert J. Mentz, Peter Öhman, Yuliya Lokhnygina, John B. Buse, Stephanie M. Gustavson, Adrian F. Hernandez, Rury R. Holman, Ambady Ramachandran and Bernard Zinman and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Jasmine Choi

17 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

2017 1.5k citations Rury R. Holman, M. Angelyn Bethel et al. New England Journal of Medicine profile →
Bacterial membrane vesicles transport their DNA cargo into host cells

2017 268 citations Natalie J. Bitto, Ross Chapman et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jasmine Choi United States	11	1.5k	783	517	321	321	19	2.3k
J. Duba Hungary	13	395 0.3×	394 0.5×	563 1.1×	81 0.3×	260 0.8×	18	1.7k
Qingqing Yang China	18	494 0.3×	374 0.5×	677 1.3×	45 0.1×	486 1.5×	89	1.7k
Wayde M. Weston United States	16	503 0.3×	670 0.9×	194 0.4×	88 0.3×	240 0.7×	26	1.6k
Izumi Takei Japan	28	848 0.6×	568 0.7×	674 1.3×	115 0.4×	129 0.4×	101	2.2k
J.H.M. Levels Netherlands	21	521 0.3×	853 1.1×	587 1.1×	38 0.1×	394 1.2×	35	2.1k
Giovam Battista Rini Italy	24	687 0.5×	284 0.4×	445 0.9×	107 0.3×	442 1.4×	60	2.3k
Rakesh S. Birjmohun Netherlands	14	377 0.2×	167 0.2×	590 1.1×	63 0.2×	153 0.5×	19	1.2k
Carol A. Seymour United Kingdom	17	166 0.1×	263 0.3×	433 0.8×	30 0.1×	194 0.6×	50	1.5k
W Jaroß Germany	19	259 0.2×	293 0.4×	648 1.3×	52 0.2×	226 0.7×	73	1.3k
Ming‐Te Huang Taiwan	28	198 0.1×	407 0.5×	1.6k 3.2×	92 0.3×	104 0.3×	78	2.5k

Countries citing papers authored by Jasmine Choi

Since Specialization

Citations

This map shows the geographic impact of Jasmine Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmine Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmine Choi more than expected).

Fields of papers citing papers by Jasmine Choi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmine Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmine Choi. The network helps show where Jasmine Choi may publish in the future.

Co-authorship network of co-authors of Jasmine Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmine Choi. A scholar is included among the top collaborators of Jasmine Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmine Choi. Jasmine Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Choi, Jasmine, et al.. (2024). Partnerships in STEAM: How Collaborating with STEAM Experts Impacts K-12 Teachers’ Abilities to Implement STEAM Lessons in the Classroom. Education Sciences. 14(6). 666–666. 1 indexed citations

Choi, Jasmine, et al.. (2024). Work-in-Progress: Pursuing STEM/STEAM Certification as a Method for Maintaining an Integrated STEM/STEAM Learning Environment. Papers on Engineering Education Repository (American Society for Engineering Education).

Xiao, Yang, Sung Wook Kang, Jiangling Dong, et al.. (2024). Sphingosine-1-Phosphate Inhibition Increases Endoplasmic Reticulum Stress to Enhance Oxaliplatin Sensitivity in Pancreatic Cancer. World Journal of Oncology. 15(2). 169–180. 1 indexed citations

Alemdar, Meltem, et al.. (2024). Exploring How Contextual Factors Influence the Implementation of Middle School Engineering Curricula (Fundamental).

Alemdar, Meltem, et al.. (2024). Exploring teachers' understanding and implementation of STEAM: one size does not fit all. Frontiers in Education. 9. 10 indexed citations

Cantoni, Claudia, Laura Ghezzi, Jasmine Choi, Anne H. Cross, & Laura Piccio. (2023). Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients. Multiple Sclerosis and Related Disorders. 76. 104839–104839. 5 indexed citations

Coffield, Julie A., Jasmine Choi, Ikseon Choi, et al.. (2021). Graduate Scholars Leadership, Engagement, And Development: Initial Design, Implementation, and Lessons Learned. Journal of higher education outreach & engagement. 25(1). 3 indexed citations

Bethel, M. Angelyn, Susanna R. Stevens, John B. Buse, et al.. (2020). Exploring the Possible Impact of Unbalanced Open-Label Drop-In of Glucose-Lowering Medications on EXSCEL Outcomes. Circulation. 141(17). 1360–1370. 10 indexed citations

Jabbour, Serge, Juan P. Frías, Azazuddin Ahmed, et al.. (2020). Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial. Diabetes Care. 43(10). 2528–2536. 49 indexed citations

10.

Mentz, Robert J., M. Angelyn Bethel, Peter Merrill, et al.. (2018). Effect of Once‐Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial. Journal of the American Heart Association. 7(19). e009304–e009304. 15 indexed citations

11.

Bitto, Natalie J., Ross Chapman, Sacha J. Pidot, et al.. (2017). Bacterial membrane vesicles transport their DNA cargo into host cells. Scientific Reports. 7(1). 7072–7072. 268 indexed citations breakdown →

12.

Holman, Rury R., M. Angelyn Bethel, Robert J. Mentz, et al.. (2017). Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine. 377(13). 1228–1239. 1503 indexed citations breakdown →

13.

Smolen, Josef S, Jung‐Yoon Choe, Nenad Prodanović, et al.. (2017). Comparing biosimilar SB2 with reference infliximab after 54 weeks of a double-blind trial: clinical, structural and safety results. Lara D. Veeken. 56(10). 1771–1779. 44 indexed citations

14.

Choe, Jung‐Yoon, Nenad Prodanović, Jaroslaw Niebrzydowski, et al.. (2015). A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy. Annals of the Rheumatic Diseases. 76(1). 58–64. 138 indexed citations

15.

Falcone, Colomba, Maria Paola Buzzi, Sara Bozzinì, et al.. (2012). Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. Journal of Nephrology. 26(1). 144–151. 10 indexed citations

16.

Falcone, Colomba, Maria Paola Buzzi, Sara Bozzinì, et al.. (2012). Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT. Mediators of Inflammation. 2012. 1–6. 10 indexed citations

17.

Mancia, Giuseppe, Gianfranco Parati, Grzegorz Bilo, et al.. (2011). Blood pressure control by the nifedipine GITS–telmisartan combination in patients at high cardiovascular risk: the TALENT study. Journal of Hypertension. 29(3). 600–609. 38 indexed citations

18.

Tardif, Jean‐Claude, John J.V. McMurray, Eric Klug, et al.. (2008). Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. The Lancet. 371(9626). 1761–1768. 147 indexed citations

19.

Davidson, Michael H., Joe S. Smith, Robert C. Scott, et al.. (2007). Assessment of lipoprotein profiles study (ALPS) and antioxidant activity in healthy subjects treated with AGI-1067. Journal of clinical lipidology. 1(4). 271–279. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact